Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Role of Imaging in Cervical Cancer

Primary Limitations of Bone Scan in Cervical Cancer

  • The American College of Radiology recommends against using MDP bone scan as the primary imaging modality for detecting bone metastases in cervical cancer due to its poor sensitivity (62-100%) and low specificity (48%) for detecting bone metastases, with the lowest sensitivity occurring in predominantly lytic lesions 3, 2
  • MDP bone scan detects metastases through osteoblastic activity, making it relatively insensitive for purely osteolytic lesions commonly found in cervical cancer 3
  • The high false-positive rate of MDP bone scan results from uptake in any process causing increased osteoblastic activity, including degenerative changes, trauma, fractures, and arthritis 3, 4
  • Bone scan cannot assess epidural disease, spinal cord compression, or neural foramina involvement—critical complications in cervical cancer with spinal metastases 1, 5
  • The American College of Radiology recommends proceeding directly to MRI without and with IV contrast as first-line imaging for cervical cancer patients with bone pain or suspected metastases 1, 2, 5
  • MRI detects very early marrow changes before cortical bone destruction occurs and provides superior assessment of spinal cord compression and epidural extension 1, 2
  • If bone scan is performed and shows positive uptake, the National Comprehensive Cancer Network recommends obtaining plain radiographs of abnormal areas to assess fracture risk, followed by MRI for definitive characterization 3
  • FDG-PET/CT is superior to bone scintigraphy for detecting lytic metastases and offers simultaneous assessment of skeletal and extraskeletal disease (sensitivity 89.7%, specificity 96.8%) 1, 5

Critical Pitfalls to Avoid

  • The National Comprehensive Cancer Network recommends never relying on bone scan alone for diagnosis—the low specificity mandates correlation with plain radiographs, CT, or MRI to characterize lesions 3, 4
  • The National Comprehensive Cancer Network advises against using bone scan to monitor treatment response, as the "flare phenomenon" from healing osteoblastic activity can misleadingly suggest disease progression 3
  • Plain radiographs require 50-70% bone destruction before detecting osteolytic changes, so negative radiographs do not exclude metastases in symptomatic patients 1, 5
  • For suspected spinal cord compression, the American College of Radiology recommends proceeding directly to MRI for treatment planning, skipping bone scan entirely 4

REFERENCES

1

nccn task force report: bone health in cancer care. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

3

Nuclear Bone Scan in Bone Pain: Diagnostic Role and Clinical Applications [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025